Doyne lecture: Trachoma, is it history

Eye

Volumn 23, Issue 11, 2009, Pages 2007-2022

  Taylor, H R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chlamydia; History; Hygiene; Reinfection; SAFE Strategy; Trachoma

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE; HEAT SHOCK PROTEIN 60; MONOCLONAL ANTIBODY; TETRACYCLINE;

ANTIBIOTIC THERAPY; BLINDNESS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CORNEA OPACITY; ENVIRONMENTAL HEALTH; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HYGIENE; IMMUNOPATHOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; REINFECTION; REVIEW; SINGLE DRUG DOSE; TRACHOMA; TRICHIASIS;

FEMALE; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; HYGIENE; MALE; PREVALENCE; RISK FACTORS; TRACHOMA; WORLD HEALTH;

EID: 70450199614     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.432     Document Type: Review

References (131)

1. Stephens RS. Chlamydial evolution: A billion years and counting. In: Schachter J, Christiansen G, Clarke IN, Hammerschlag MR, Kaltenboeck B, Kuo C-C et al. (eds). Chlamydial Infections; 2002. Proceedings of the Tenth International Symposium on Human Chlamydial Infections; 2002. Antalya-Turkey: International Chlamydia Symposium: San Francisco, 2002, pp 3-12.
2. Marrazzo JM. Epidemiology of Chlamydia trachomatis genital infections: what's new since 2002. In: Chernesky M, Caldwell H, Christiansen G, Clarke IN, Kaltenboeck B, Knirsch C et al. (eds). Proceedings of the Eleventh International Symposium on Human Chlamydial Infections; 2006. Niagaraon- the-Lake, Ontario, Canada: International Chlamydia Symposium: San Francisco, 2006, pp 59-68.
3. Duke-Elder S, Wybar KC. System of Ophthalmology. The Anatomy of the Visual System. The CV Mosby Company: St Louis, 1961.
4. Taylor HR. Trachoma: A Blinding Scourge from the Bronze Age to the Twenty-first Century. Centre for Eye Research Australia: Melbourne, 2008.
5. Hirschberg J. The History of Ophthalmology, in Eleven Volumes 1: Antiquity. JP Wayenborgh Verlag: Bonn, 1982.
6. Millar MI, Lane SD. Ethno-ophthalmology in the Egyptian delta: An historical systems approach to ethnomedicine in the Middle East. Soc Sci Med 1988; 26: 651-657.
7. Boldt J. Trachoma. Hodder and Stoughton: London, 1904.
8. Celsus AC. De Medicina (On Medicine) Celsus On Medicine Book VI. Loeb Classical Library 1935, 1935. available at: http://penelope.uchicago.edu/Thayer/ E/Roman/Texts/ Celsus/6*.html, accessed July 2006.
9. MacCallan AF. Trachoma and its Complications in Egypt. Cambridge University Press: Cambridge, 1913.
10. Hirschberg J. The History of Ophthalmology, in Eleven Volumes 2: The Middle Ages; The Sixteenth and Seventeenth Centuries. JP Wayenborgh Verlag: Bonn, 1985.
11. Meyerhof M. A short history of ophthalmia during the Egyptian campaigns of 1798-1807. Br J Ophthalmol 1932; 16: 129-152.
12. Vetch J. An Account of the Ophthalmia which Appeared in England since the Return of the British Army from Egypt. Longman, Hurst, Rees & Orme: London, 1807.
13. Davidson L. 'Identities Ascertained': British Ophthalmology in the First Half of the Nineteenth Century. Soc Hist Med. 1996; 9: 313-333.
14. Treacher Collins E. The History & Traditions of the Moorfields Eye Hospital. One Hundred Years of Ophthalmic Discovery & Development. H.K. Lewis & Co Ltd: London, 1929.
15. Sorsby A, Sorsby M. A Short History of Ophthalmology. Staples Press: London, New York, 1948.
16. Donovan P. 'An Ornament to the City' The Royal Victorian Eye and Ear Hospital. The Royal Victorian Eye & Ear Hospital: Melbourne, 1992.
17. Wilde RW. The organs of sight and hearing. Lancet 1845; pp 431-435.
18. Duke-Elder S. A Century of International Ophthalmology (1857-1957). Henry Kimpton: London, 1958.
19. Allen SK, Semba RD. The trachoma 'Menace' in the United States, 1897-1960Fhistory of ophthalmology. Surv Ophthalmol 2002; 47: 500-509.
20. McMullen J. Trachoma, its prevalence and control among immigrants. JAMA 1913; 61: 1110-1113.
21. Sorsby A. The treatment of trachoma. With special reference to local sulphonamide therapy. Br J Ophthalmol 1945; 29: 98-102.
22. Jones BR. Changing concepts of trachoma and its control. Trans Ophthalmol Soc UK 1980; 100: 25-29.
23. Friederich R. Eye disease in the Navajo Indians. Ann Ophthalmol 1982; 14: 38-40.
24. World Health Organization. Report of the 2nd Global Scientific Meeting on Trachoma. WHO: Geneva, Switzerland, 2003.
25. Tellis B, Keeffe JE, Taylor HR, National Trachoma Surveillance and Reporting Unit. Surveillance report for active trachoma, 2006. Comm Dis Bull 2007; 31: 366-374.
26. Thygeson P. Epidemiologic observations on trachoma in the United States. Invest Ophthalmol 1963; 2: 482-489.
27. World Health Organization. Fourth WHO Scientific Group on Trachoma Research, (report) WHO: Geneva, 1966.
28. Dawson CR, Jones BR, Tarizzo ML. Guide to Trachoma Control. World Health Organization: Geneva, 1981.
29. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complication. Bull World Health Organ 1987; 65: 477-483.
30. Solomon AW, Zondervan M, Kuper H, Buchan JC, Mabey DCW, Foster A. Trachoma ControlFA Guide for Programme Managers. World Health Organization: Geneva, 2006.
31. Benedek TG. Gonorrhea and the beginnings of clinical research ethics. Perspect Biol Med 2005; 48: 54-73.
32. Halberstaedter L, von Prowazek S. Uber zelleinschusse parasitarer natur beim trachom (On cell inclusions of a parasitic nature in trachoma). Arb K Gesundh Amt 1907; 26: 44-47.
33. T'ang FF, Chang HL, Huang YT, Wang KC. Studies on the etiology of trachoma with special reference to isolation of the virus in chick embryo. Chin Med J 1957; 75: 429-447.
34. Gordon FB, Quan AL. Isolation of the trachoma agent in cell culture. Proc Soc Exp Biol Med 1965; 118: 354-359.
35. Wilson MC, Millan-Velasco F, Tielsch JM, Taylor HR. Direct-smear fluorescent antibody cytology as a field diagnostic tool for trachoma. Arch Ophthalmol 1986; 104: 688-690.
36. Caldwell HD, Schachter J. Immunoassay for detecting Chlamydia trachomatis major outer membrane protein. J Clin Microbiol 1983; 18: 539-545.
37. Taylor HR, Rapoza PA, West S, Johnson S, Muñoz B, Katala S et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci 1989; 30: 1823-1833.
38. Taylor HR, Siler JA, Mkocha HA, Muñoz B, Velez V, DeJong L et al. The microbiology of endemic trachomaFa longitudinal study. J Clin Microbiol 1991; 29: 1593-1595.
39. Dean D, Pant CR, O'Hanley P. Improved sensitivity of a modified polymerase chain reaction amplified DNA probe in comparison with serial tissue culture passage for detection of Chlamydia trachomatis in conjunctival specimens from Nepal. Diagn Microbiol Infect Dis 1989; 12: 133-137.
40. Yang JL, Schachter J, Moncada J, Habte D, Zerihun M, House JI et al. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br J Ophthalmol 2007; 91: 293-295. (Pubitemid 46586520)
41. Solomon AW, Holland MJ, Burton MJ, West SK, Alexander NDE, Aguirre A et al. Strategies for control of trachoma: Observational study with quantitative PCR. Lancet 2003; 362: 198-204.
42. Solomon AW, Peeling RW, Foster A, Mabey DCW. Diagnosis and assessment of trachoma. Clin Microbiol Rev 2004; 17: 982-1011.
43. Miller K, Schmidt G, Alemayehu W, Yi E, Cevallos V, Donnellan C et al. How reliable is the clinical exam in detecting ocular chlamydial infection. Ophthalmic Epidemiol 2004; 11: 255-262.
44. Wright HR, Taylor HR. Clinical examination and laboratory tests for estimation of trachoma prevalence in remote settings. Lancet 2006; 6: 7-8.
45. Baral K, Osaki S, Shreshta B, Panta CR, Boulter A, Pang F et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull World Health Organ 1999; 77: 461-466.
46. Nicolle C, Cuenod A, Baizot L. Etude experimentale du trachome. Arch Instit Pasteur de Tunis 1913; 4: 157-182.
47. Dawson CR, Wood TR, Rose L, Hanna L, Thygeson P. Experimental inclusion conjunctivitis in man. III. Keratitis and other complications. Arch Ophthalmol 1967; 78: 341-349.
48. Thygeson P, Dawson C, Hanna L, Jawetz E, Okumoto M. Observations on experimental trachoma in monkeys produced by strains of viruses propagated in yolk sac. Am J Ophthalmol 1960; 50: 907-918.
49. Wang S-P, Grayston JT. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol 1967; 63: 1133-1145.
50. Dawson CR, Jawetz E, Thygeson P, Hanna L. Trachoma viruses isolated in the United States. 4. Infectivity and immunogenicity for monkeys. Proc Soc Exp Biol Med 1961; 106: 898-902.
51. Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, Silverstein AM. An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci 1982; 23: 507-519.
52. Mitsui Y, Higai H, Kitamuro T. Free toxic substance of trachoma virus. Arch Ophthalmol 1962; 68: 651-653.
53. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L et al. Genome sequence of an obligate intracellular pathogen of human: Chlamydia trachomatis. Science 1998; 282: 754-759.
54. Caldwell HD, Stewart S, Johnson S, Taylor H. Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect Immun 1987; 55: 93-98.
55. Taylor HR, Johnson SL, Schachter J, Caldwell HD, Prendergast RA. Pathogenesis of trachoma: The stimulus for inflammation. J Immunol 1987; 138: 3023-3027.
56. Taylor HR, Maclean IW, Brunham RC, Pal S, Whittum- Hudson J. Chlamydial heat-shock proteins and trachoma. Infect Immun 1990; 58: 3061-3063.
57. Whittum-Hudson JA, Taylor HR. Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection. Infect Immun 1989; 57: 2977-2983.
58. Pal S, Pu Z, Huneke RB, Taylor HR, Whittum-Hudson JA. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: Limiting dilution analysis. Reg Immunol 1991; 3: 171-176.
59. Bavoil PM, Wyrick PB (eds). Chlamydia: Genomics and Pathogenesis. Horizon Bioscience: Norfolk, UK, 2006.
60. Grayston JT, Wang S. New knowledge of Chlamydiae and the diseases they cause. J Infect Dis 1975; 132: 87-105.
61. Bietti G, Werner GH. Trachoma Prevention and Treatment. Charles C Thomas: Springfield, Illinois, 1967.
62. Polack S, Brooker S, Kuper H, Mariotti S, Mabey D, Foster A. Mapping the global distribution of trachoma. Bull World Health Organ 2005; 83: 913-919.
63. Nichols RL, Von Fritzinger K, McComb DE. Epidemiological data derived from immunotyping of 338 trachoma strains isolated from children in Saudi Arabia. In: Nichols RL (ed.) Trachoma and Related Disorders Caused by Chlamydial Agents. Excerpta Medica: Amsterdam, 1971, pp 337-357.
64. Taylor HR, Siler JA, Mkocha HA, Muñoz B, West S. The natural history of endemic trachoma: A longitudinal study. Am J Trop Med Hyg 1992; 46: 552-559.
65. Bailey RL, Hayes L, Pickett M, Whittle HC, Ward ME, Mabey DCW. Molecular epidemiology of trachoma in a Gambian village. Br J Ophthalmol 1994; 78: 813-817.
66. Bobo LD, Novak N, Munoz B, Hsieh YH, Quinn TC, West S. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis 1997; 176: 1524-1530.
67. Zhang J, Lietman TM, Olinger L, Miao Y, Stephens RS. Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma. Pediatr Infect Dis J 2004; 23: 2057-2060.
68. Broman AT, Shum K, Munoz B, Duncan DD, West SK. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci 2006; 47: 99-104.
69. Nichols RL, Bobb AA, Haddad NA, McComb DE. Immunofluorescent studies of the microbiologic epidemiology of trachoma in Saudi Arabia. Am J Ophthalmol 1967; 63: 1372-1408.
70. Ministry of Public Health. Fourteenth Report of the Memorial Ophthalmic Laboratory 1939-1944. Ministry of Public Health: Giza, Cairo, 1945.
71. Royal Australian College of Ophthalmologists. The National Trachoma and Eye Health Program of the Royal Australian College of Ophthalmologists. Royal Australian College of Ophthalmologists: Sydney, 1980.
72. Jones BR. The prevention of blindness from trachoma (Bowman Lecture). Trans Ophthalmol Soc UK 1975; 95: 16-33.
73. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: A longitudinal study. Lancet 2005; 366: 1296-1300. (Pubitemid 41416585)
74. West SK, Munoz B, Lynch M, Kayongoya A, Mmbaga BBO, Taylor HR. Risk factors for constant, severe trachoma in pre-school children in Kongwa, Tanzania. Am J Epidemiol 1996; 143: 73-78.
75. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 2001; 8: 137-144.
76. World Health Organization. Expert Committee on Trachoma, (third report). WHO: Geneva, 1962.
77. Taylor HR, Millan-Velasco F, Sommer A. The ecology of trachoma: An epidemiological study of trachoma in Southern Mexico. Bull World Health Organ 1985; 63: 559-567.
78. Tielsch JM, West Jr KP, Katz J, Keyvan-Larijani E, Tizazu T, Schwab L et al. The epidemiology of trachoma in southern Malawi. Am J Trop Med Hyg 1988; 38: 393-399.
79. Taylor HR, West SK, Mmbaga BBO, Katala SJ, Turner V, Lynch M et al. Hygiene factors and increased risk of trachoma in Central Tanzania. Arch Ophthalmol 1989; 107: 1821-1825.
80. Courtright P, Sheppard J, Lane S, Sadek A, Schachter J, Dawson CR. Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol 1991; 75: 322-325.
81. Luna EJA, Medina NH, Oliveira MB, De Barros OMD, Vranjac A, Melles HHB et al. Epidemiology of trachoma in Bebedouro State of Sao Paulo, Brazil: Prevalence and risk factors. Int J Epidemiol 1992; 21: 169-177.
82. Katz J, West KP, Khatry SK, LeClerq SC, Pradhan EK, Thapa MD et al. Prevalence and risk factors for trachoma in Sarlahi district, Nepal. Br J Ophthalmol 1996; 80: 1037-1041.
83. Sahlu T, Larson C. The prevalence and environmental risk factors for moderate and severe trachoma in southern Ethiopia. J Trop Med Hyg 1992; 95: 36-41.
84. Schemann J-F, Sacko D, Malvy D, Momo G, Traore L, Bore O et al. Risk factors for trachoma in Mali. Int J Epidemiol 2002; 31: 194-201.
85. Schemann JF, Guinot C, Ilboudo L, Momo G, Ko B, Sanfo O et al. Trachoma, flies and environmental factors in Burkina Faso. Trans R Soc Trop Med Hyg 2003; 97: 63-68.
86. Cumberland P, Hailu G, Todd J. Active trachoma in children aged three to nine years in rural communities in Ethiopia: Prevalence, indicators and risk factors. Trans Roy Soc Trop Med Hyg 2005; 99: 120-127.
87. Faye M, Kuper H, Dineen BP, Bailey R. Rapid assessment for prioritisation of trachoma control at community level in one district of the Kaolack region, Senegal. Trans Roy Soc Trop Med Hyg 2006; 100: 149-157.
88. Mesfin MM, de la Camera J, Tareke IG, Amanual G, Araya T, Kedir AM. A community-based trachoma survey: Prevalence and risk factors in the Tigray region of Northern Ethiopia. Ophthalmic Epidemiol 2006; 13: 173-181.
89. Abdou A, Nassirou B, Kadri B, Moussa F, Munoz BE, Opong E et al. Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger. Br J Ophthalmol 2007; 91: 13-17.
90. Sorsby MA. Trachoma in Great Britain. Rev Int Trach 1939; 16: 148-155.
91. West S, Taylor HR. Community based intervention programs for trachoma control. Int Ophthalmol 1988; 12: 19-23.
92. MacCallan AF. Trachoma. Butterworth & Co. (Publishers) Ltd: London, 1936.
93. McCauley AP, Lynch M, Pounds MB, West S. Changing water-use patterns in a water-poor area: Lessons for a trachoma intervention project. Soc Sci Med 1990; 31: 1233-1238.
94. Mabey DCW, Downes RM, Downes B, Bailey RL, Dunn DT. The impact of medical services on trachoma in a Gambian village: Antibiotics alone are not the answer. Ann Trop Paediatrics 1991; 11: 295-300.
95. Francis V, Turner V. Achieving Community Support for Trachoma Control. World Health Organization: Geneva, 1993. Report no.: WHO/PBL/93.36.
96. Reacher M, Foster A, Huber J. Trichiasis Surgery for TrachomaFthe Bilamellar Tarsal Rotation Procedure. World Health Organization: Geneva, 1993. Report no.: WHO/ PBL/93.29.
97. El Toukhy E, Lewallen S, Courtright P. Routine bilamellar tarsal rotation surgery for trachomatous trichiasis: Short-term outcome and factors associated with surgical failure. Ophthal Plast Reconstr Surg 2006; 22: 109-112.
98. Merbs SL, West SK, West ES. Pattern of recurrence of trachomatous trichiasis after surgery. Ophthalmology 2005; 112: 705-709.
99. http://www.who.int/blindness/publications/get2020/ en/index.html.S. Report of the Eleventh Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma, Cairo, 2-4 April, 2007; accessed June 2008.
100. West SK, West ES, Alemayehu W, Melese M, Munoz B, Imeru A et al. Single-dose azithromycin prevents trichiasis recurrence following surgery. Arch Ophthalmol 2006; 124: 309-314.
101. Zhang H, Kandel RP, Atakari HK, Dean D. Impact of oral azithromycin on recurrence of trachmatous trichiasis in Nepal over 1 year. Br J Ophthalmol 2006; 90: 943-948.
102. Bowman RJ, Soma OS, Alexander N, Milligan P, Rowley J, Faal H et al. Should trichiasis surgery be offered in the village? A community-randomised controlled trial of village vs community health center-basd surgery. Trop Med Int Health 2000; 5: 528-533.
103. Mahande M, Tharaney M, Kirumbi E, Ngirawamungu E, Geneau R, Tapert L et al. Uptake of trichiasis surgical services in Tanzania through two village-based approaches. Br J Ophthalmol 2007; 91: 139-142.
104. West S, Nguyen MP, Mkocha H, Holdsworth G, Ngirwamungu E, Kilima P et al. Gender equity and trichaisis surgery in the Vietnam and Tanzania national trachoma control programmes. Br J Ophthalmol 2004; 88: 1368-1371.
105. Courtright P. Acceptance of surgery for trichiasis among rural Malawian women. East Afr Med J 1994; 71: 803-804.
106. Dhaliwal U, Nagpal G, Bhatia MS. Health-related quality of life in patients with trachomatous trichiasis or Entropion. Ophthalmic Epidemiol 2006; 13: 59-66.
107. Rees E, Tait IA, Hobson D, Karayiannis P, Lee N. Persistence of chlamydial infection after treatment for neonatal conjunctivitis. Arch Dis Child 1981; 56: 193-198.
108. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55: 1-94.
109. Hoepelman IM, Schneider MME. Azithromycin: The first of the tissue-selective azalides. Int J Antimicrob Agents 1995; 5: 145-167.
110. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992; 327: 921-925.
111. Mabey D, Fraser-Hurt N, Powell C. Antibiotics for Trachoma. Cochrane Database Syst Rev 2005; CD001860.
112. Fry AM, Jha HC, Lietman TM, Chaudhary JSP, Bhatta RC, Elliott J et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 2002; 35: 395-402.
113. Shelby-James TM, Leach AJ, Carapetis JR, Currie BJ, Mathews JD. Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children. Ped Infect Dis J 2002; 21: 375-380.
114. Sarkar M, Woodland C, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
115. Solomon AW, Harding-Esch E, Alexander NDE, Aguirre A, Holland MJ, Bailey RL et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Eng J Med 2008; 358: 1870-1871.
116. West S, Muñoz B, Lynch M, Kayongoya A, Chilangwa Z, Mmbaga BBO et al. Impact of face-washing on trachoma in Kongwa Tanzania. Lancet 1995; 345: 155-158.
117. Edwards T, Cumberland P, Hailu G, Todd J. Impact of health education on active trachoma in hyperendemic rural communities in Ethiopia. Ophthalmology 2006; 113: 548-555.
118. Ngondi J, Onsarigo A, Matthews F, Reacher M, Brayne C, Baba S et al. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: A cross sectional study. Lancet 2006; 368: 589-595.
119. Emerson PM, Lindsay SW, Alexander N, Bah M, Dibba S, Faal HB et al. Role of flies and provision of latrines in trachoma control: Cluster-randomised controlled trial. Lancet 2004; 363: 1093-1098.
120. West SK, Emerson PM, Mkocha H, Mchiwa W, Munoz B, Bailey R et al. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: A randomised trial. Lancet 2006; 368: 596-600.
121. Astle WF, Wiafe B, Ingram AD, Mwanga M, Glassco CB. Trachoma control in southern ZambiaFan international team project employing the SAFE strategy. Ophthalmic Epidemiol 2006; 13: 227-236.
122. Ewald DP, Hall GV, Franks CC. An evaluation of a SAFE-style trachoma control program in Central Australia. Med J Aust 2003; 178: 65-68.
123. Lansingh VC. Primary Health Care Approach to Trachoma Control in Aboriginal Communities in Central Australia [PhD]. University of Melbourne: Melbourne, 2005.
124. World Health Organization. Report of the Ninth Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. WHO: Geneva 21-23 March 2005. Report no.: WHO/PBD/GET/05.1. 125 /http://www.un.org/milleniumgoals/ S. UN Millennium Goals; 2005, accessed on September 2006.
125. Frick KD, Hanson CL, Jacobson GA. Global burden of trachoma and economics of the disease. Am J TropMed Hyg 2003; 69: 1-10.
126. Frick KD, Melia M, Buhrmann RB, West SK. Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol 2001; 119: 1839-1844.
127. Baltussen RM, Sylla M, Frick KD, Mariotti SP. Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol 2005; 12: 91-101.
128. Frick KD, Lietman TM, Holm SO, Jha HC, Chaudary JSP, Bhatta RC. Cost-effectiveness of trachoma control measures: Comparing targeted household treatment and mass treatment of children. Bull World Health Organ 2001; 79: 201-207.
129. http://www.who.int/en/S. World Health Organization, accessed June 2008.
130. http://www.pfizer.com/pfizer/history/1998.jspS. Exploring Our History. 1951-1999. 1998FTrachoma; 2006, accessed September 2006.
131. Sidky MM, Freyce MS. World distribution and prevalence of trachoma in recent years. Epidem Vital Stat Rep 1949; II: 230-277.